MYCOPHENOLATE

MYCOPHENOLATE (13884R)

mycophenolate mofetil 250 mg capsule, 100
13884R
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 600 # of repeats: 5 DPMQ: $138.84 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Mycophenolate
Mycophenolate Sandoz
Pharmacor Mycophenolate 250

MYCOPHENOLATE (6208R)

mycophenolate mofetil 250 mg capsule, 100
6208R
Body System:
Manner of administration:Oral
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9689)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9690)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy )
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 600 # of repeats: 5 DPMQ: $128.70 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Mycophenolate
Mycophenolate Sandoz
Pharmacor Mycophenolate 250

MYCOPHENOLATE (8649F)

mycophenolate mofetil 250 mg capsule, 100
8649F
Body System:
Manner of administration:Oral
General Schedule
No restrictions
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 3 Max qty units: 300 # of repeats: 5 DPMQ: $75.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Mycophenolate
Mycophenolate Sandoz
Pharmacor Mycophenolate 250

MYCOPHENOLATE (9501C)

mycophenolate mofetil 250 mg capsule, 100
9501C
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 5653)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 5600)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 600 # of repeats: 5 DPMQ: $115.20 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Mycophenolate
Mycophenolate Sandoz
Pharmacor Mycophenolate 250